Generation Bio Co.
GBIO
$6.35
$0.223.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.23M | 24.56M | 19.89M | 18.58M | 13.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.23M | 24.56M | 19.89M | 18.58M | 13.17M |
| Cost of Revenue | 47.85M | 48.71M | 47.77M | 57.14M | 63.71M |
| Gross Profit | -26.62M | -24.16M | -27.88M | -38.56M | -50.54M |
| SG&A Expenses | 48.31M | 50.08M | 51.59M | 58.99M | 61.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 96.16M | 98.79M | 99.37M | 116.13M | 125.37M |
| Operating Income | -74.93M | -74.24M | -79.47M | -97.55M | -112.19M |
| Income Before Tax | -72.42M | -71.93M | -131.67M | -145.47M | -158.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -72.42 | -71.93 | -131.67 | -145.47 | -158.43 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -72.42M | -71.93M | -131.67M | -145.47M | -158.43M |
| EBIT | -74.93M | -74.24M | -79.47M | -97.55M | -112.19M |
| EBITDA | -70.30M | -69.48M | -74.54M | -92.47M | -107.00M |
| EPS Basic | -10.83 | -10.78 | -19.79 | -21.91 | -23.91 |
| Normalized Basic EPS | -6.20 | -6.07 | -6.45 | -8.08 | -9.44 |
| EPS Diluted | -10.83 | -10.78 | -19.79 | -21.91 | -23.91 |
| Normalized Diluted EPS | -6.20 | -6.07 | -6.45 | -8.08 | -9.44 |
| Average Basic Shares Outstanding | 26.76M | 26.71M | 26.65M | 26.58M | 26.49M |
| Average Diluted Shares Outstanding | 26.76M | 26.71M | 26.65M | 26.58M | 26.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |